We are developing a bioelectronic solution for migraine
As a pioneer in the field of medical devices, Salvia BioElectronics is passionately committed to empowering people with migraine to reclaim their lives. Our personalized migraine therapy is tailored to the needs of individual patients. And our ambition does not stop there. With our unique bioelectronic technology, we are also exploring applications for other neurological disorders. Our unwavering commitment is driven by a deep desire to restore hope, health and happiness to people around the globe by improving the overall well-being and quality of life for individuals and their families.
Salvia’s migraine therapy is currently being evaluated in clinical studies. It has not yet been approved for commercial use. No claims are made regarding its safety or effectiveness.
Meet our team
Salvia BioElectronics has experienced remarkable growth over the past seven years. We now have 50+ colleagues from all over the world, representing 15 nationalities. Our home is High Tech Campus Eindhoven, also known as the smartest square kilometer in Europe, where more than 300 high-tech companies are developing the technologies of the future.
Our team
Salvia Selected for MedTech Innovator Accelerator 2024
Salvia BioElectronics is one of the companies selected for the MedTech Innovator Accelerator 2024. "We are absolutely thrilled," says Salvia CEO Hubert Martens. "With over 1300 applicants, only the top 5% made it through the rigorous selection process; this is an amazing group to be a part of. We're looking forward to connecting with like-minded entrepreneurs and are excited to have the opportunity to learn from the best in class and get expert support to further detail and pressure test our commercialization plans."
It is not “just a headache”
Migraine affects more than one billion people worldwide each year and is the leading cause of disability in people under 50. Cluster headache, which causes excruciating pain behind the eye, is a rare neurological disorder affecting 1 in 1000 people. Read more about both conditions we address with our bioelectronic solution.
Join our team
Our team is growing and we are always looking for passionate and talented individuals who want to be part of our mission to give people with migraine a better life.
We also encourage open applications; please submit yours here!
Acquisition is not appreciated.
Director R&D
We offer a challenging new position for a Director R&D. This role requires a blend of technical expertise, and leadership abilities to grow and guide a multidisciplinary team of scientists, engineers and project managers. You report to the VP Product Development. As part of Salvia’s Leadership Team, you help shape the company’s strategic agenda and translate business ambitions into tangible goals and R&D objectives.
.jpg)
Supply Chain Planner
You ensure a smooth planning process across the supply chain from shopfloor up to our customers, and from our suppliers to our finished goods inventory. You ensure that the planning is aligned and communicated with all relevant stakeholders inside Salvia and with our OEM suppliers.
Stay informed
First patient in the Netherlands receives promising migraine implant in clinical study
For the first time in the Netherlands, a patient has been implanted with an ultra-thin implant for chronic migraine as part of a clinical study. The procedure was conducted at Erasmus MC in Rotterdam.
Meet Ingelou Stol, Director Marketing Communications
Since 2023, Ingelou has been at the heart of Salvia’s brand - driving strategic communications, shaping the company’s positioning, and leading patient engagement. She also plays a key role in crafting communications for patients and physicians in Salvia’s clinical studies.
Meet Aniruddha Phatak, Senior Process Development Engineer
Aniruddha “Andy” Phatak’s fascinating career spans continents and disciplines, taking him from India to Salvia. Along the way, he published an MS thesis downloaded in 71 countries, assisted in spinal surgeries on cadavers, and became an ISO 13485 Lead Auditor, performing audits across the U.S and India.
Meet our investors
Salvia Insights
Starting in 2025, we will provide updates on our latest clinical trials and other developments. Stay informed about Salvia's mission?
We value your privacy and will only use your email to send you updates about Salvia BioElectronics. Your information will always remain confidential and will not be shared with third parties. You can unsubscribe at any time.